2004
DOI: 10.1016/j.exphem.2004.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

8
184
3
10

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 247 publications
(205 citation statements)
references
References 72 publications
8
184
3
10
Order By: Relevance
“…Many studies have been performed to try and substitute the animal serum with human autologous or allogeneic serum or with synthetic media, but have not usually produced satisfactory results. [13][14][15] The addition of the PL has been suggested previously, [16][17][18] but the exact determination of hMSC yield starting from a reduced number of nucleated cells to reach clinically relevant numbers has never been shown previously.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies have been performed to try and substitute the animal serum with human autologous or allogeneic serum or with synthetic media, but have not usually produced satisfactory results. [13][14][15] The addition of the PL has been suggested previously, [16][17][18] but the exact determination of hMSC yield starting from a reduced number of nucleated cells to reach clinically relevant numbers has never been shown previously.…”
Section: Discussionmentioning
confidence: 99%
“…Autologous serum represents another alternative to FCS for cell expansion. Studies have demonstrated the possibility to replace FCS for expansion of human mesenchymal stem cells (Stute et al 2004, Shahdadfar et al 2005. In human chondrocytes recent data have demonstrated higher proliferation rates of articular and auricular chondrocytes in autologous and allogenic human serum in comparison to FCS (Tallheden et al 2005, Yanaga et al 2006.…”
Section: Discussionmentioning
confidence: 99%
“…If the cells have been exposed to FCS during cultivation, the following transplantation may induce immune or local inflammatory responses (Selvaggi et al 1997, Heiskanen et al 2007. Therefore, the development of FCS-free culturing protocols certainly represents an advantage for future development of cellular therapies, and the use of serum-free media, allogenic, and autologous serum have being already investigated as potential alternatives for growing cells in human regenerative medicine (Stute et al 2004, Shahdadfar et al 2005, Tallheden et al 2005. In addition to serum-supplementation, chondrocyte proliferation rates in monolayer culture have been shown to depend on factors such as the cell-seeding density (Mandl et al 2004) or the age of the donor (Barbero et al 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Human BMSCs have been successfully cultured and grown in AS-supplemented medium [3,12,15]. Most of these cases involved the use of a culture medium supplemented with 10% AS, with no significant differences reported in the morphology or proliferation capacity of BMSCs compared to culturing with media with 10 or 20% FBS [3,10,12,15].…”
mentioning
confidence: 99%
“…In the clinical application of BMSCs, the use of fetal bovine serum (FBS) during culturing has been called into question and many investigations into culture methods without FBS are underway [6,12]. One proposed solution is the use of a culture medium supplemented with autologous serum (AS).…”
mentioning
confidence: 99%